NKG2C, HLA-E and their association with psoriasis

被引:13
|
作者
Patel, Forum [1 ]
Marusina, Alina I. [1 ]
Duong, Christopher [1 ]
Adamopoulos, Iannis E. [2 ]
Maverakis, Emanual [1 ,3 ]
机构
[1] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95816 USA
[2] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Dept Internal Med, Sacramento, CA 95816 USA
[3] Vet Affairs Northern Calif Hlth Care Syst, Dept Dermatol, Sacramento, CA USA
关键词
antigen processing; HLA-Cw*0602; HLA-E; natural killer cells; NK T cells; NKG2A; NKG2C; psoriasis; NATURAL-KILLER-CELLS; DENDRITIC CELLS; NK CELLS; ACTIVATION; RECEPTOR; CD94/NKG2A; PROMOTES; SKIN;
D O I
10.1111/exd.12280
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Natural killer (NK) cell activation is regulated by the integration of signals from inhibitory and activating cell surface receptors. Both NKG2A and NKG2C pair with CD94 to form inhibitory and activating receptors specific for the HLA-E-canonical peptide complex. HLA-E is a non-classical MHC class Ib molecule with limited polymorphism. It preferentially binds to and presents leader sequence peptides derived from classical MHC class I molecules. Wilson etal. have identified an association between NKG2C deficiency and psoriasis. They have also discovered an HLA-C-dependent association between HLA-E and psoriasis. Their research highlights the importance of NK cells in the pathophysiology of psoriasis. Herein, we propose two different models to explain the association between NKG2C, HLA-E and psoriasis. In the first model, we hypothesize that NKG2C deficiency and/or HLA-E O1:01 can inhibit the ability of NK cells to regulate autoreactive T cells, predisposing to psoriasis. The second model proposes that HLA-E 01:03 can disrupt the presentation of the psoriasis-inducing self-determinant by HLA-C, thereby protecting against psoriasis.
引用
收藏
页码:797 / 799
页数:3
相关论文
共 50 条
  • [31] NKG2C gene deletion in the Mexican population and lack of association to respiratory viral infections
    Rangel-Ramirez, V. V.
    Garcia-Sepulveda, C. A.
    Escalante-Padron, F.
    Perez-Gonzalez, L. F.
    Rangel-Castilla, A.
    Aranda-Romo, S.
    Noyola, D. E.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2014, 41 (02) : 126 - 130
  • [32] NKG2C Deletion Is a Risk Factor of HIV Infection
    Thomas, Rachel
    Low, Hui Zhi
    Kniesch, Katja
    Jacobs, Roland
    Schmidt, Reinhold E.
    Witte, Torsten
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (08) : 844 - 851
  • [33] On the diversity of HLA-E: Identification of a novel HLA-E allele
    Forstmann, G
    Blasczyk, R
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P367 - P367
  • [34] HLA-E:CD94-NKG2A MEDIATES CIRCULATING TUMOR CELL IMMUNE EVASION
    Liu, X.
    Song, J.
    Zhang, H.
    Liu, X.
    Zuo, F.
    Zhao, Y.
    CANCER DISCOVERY, 2023, 13 (04)
  • [35] Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
    Subhashis Sarkar
    Michel van Gelder
    Willy Noort
    Yunping Xu
    Kasper M. A. Rouschop
    Richard Groen
    Harry C. Schouten
    Marcel G. J. Tilanus
    Wilfred T. V. Germeraad
    Anton C. M. Martens
    Gerard M. J. Bos
    Lotte Wieten
    Cancer Immunology, Immunotherapy, 2015, 64 : 951 - 963
  • [36] HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors
    Posch, PE
    Borrego, F
    Brooks, AG
    Coligan, JE
    JOURNAL OF BIOMEDICAL SCIENCE, 1998, 5 (05) : 321 - 331
  • [37] NKG2A AND HLA-E DEFINE A NOVEL ALTERNATIVE IMMUNE CHECKPOINT AXIS IN BLADDER CANCER
    Salome, Berengere
    Sfakianos, John
    Charap, Andrew
    Farkas, Adam
    Geanon, Daniel
    Kelly, Geoffrey
    de Real, Ronaldo
    Lee, Brian
    Beaumont, Kristin
    Shroff, Sanjana
    Wang, Ying-Chih
    Wang, Yuan-Shuo
    Wang, Li
    Sebra, Robert
    Kamphorst, Alice
    Malmberg, Karl-Johan
    Marcenaro, Emanuela
    Romero, Pedro
    Brody, Rachel
    Yuki, Yuko
    Martin, Maureen
    Carrington, Mary
    Mehrazin, Reza
    Wiklund, Peter
    Zhu, Jun
    Galsky, Matthew
    Bhardwaj, Nina
    Horowitz, Amir
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A338 - A338
  • [38] Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
    Sarkar, Subhashis
    van Gelder, Michel
    Noort, Willy
    Xu, Yunping
    Rouschop, Kasper M. A.
    Groen, Richard
    Schouten, Harry C.
    Tilanus, Marcel G. J.
    Germeraad, Wilfred T. V.
    Martens, Anton C. M.
    Bos, Gerard M. J.
    Wieten, Lotte
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (08) : 951 - 963
  • [39] NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer
    Salome, Berengere
    Sfakianos, John P.
    Daza, Jorge
    Charap, Andrew
    Farkas, Adam M.
    Geanon, Daniel
    Kelly, Geoffrey
    De Real, Ronaldo M.
    Lee, Brian
    Beaumont, Kristin G.
    Shroff, Sanjana
    Wang, Ying-Chin
    Wang, Yuan-Shuo A.
    Wang, Li
    Sebra, Robert P.
    Kamphorst, Alice O.
    Malmberg, Karl J.
    Marcenaro, Emanuela
    Romero, Pedro
    Brody, Rachel
    Yuki, Yuko
    Martin, Maureen
    Carrington, Mary
    Mehrazin, Reza
    Wiklund, Peter
    Zhu, Jun
    Galsky, Matthew D.
    Bhardwaj, Nina
    Horowitz, Amir
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [40] Selective Expansion of NKG2C+Adaptive NK Cells Using K562 Cells Expressing HLA-E
    Phan, Minh-Trang Thi
    Kim, Jinho
    Koh, Seung Kwon
    Lim, Yuree
    Yu, Hongbi
    Lee, Mijeong
    Lee, Jong-Min
    Kang, Eun-Suk
    Kim, Hyun-Young
    Kim, Sang-Ki
    Hwang, Ilwoong
    Cho, Duck
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)